Successful inactivation of Twist1 in cancer cells by siRNA or chemotherapeutic approaches has been reported [20–23], and inhibitors targeting either the upstream regulator or downstream effector of Twist1 signaling have also been identified for cancer therapy [24]. This evidence concerns the gene TWIST1 and cancer.